Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories
-
Form NPORT-P/A Lincoln Bain Capital For: Mar 31
-
GraniteShares launches leveraged SpaceX ETFs as company goes public
-
Form D/A Bain Capital Structured
-
BioGene Therapeutics appoints Ty Howton to board of directors
-
Form N-CSR Lincoln Bain Capital For: Mar 31
-
Form N-CEN Lincoln Bain Capital For: Mar 31
-
Form N-23C3A Lincoln Bain Capital For: Jun 02
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form 8-K Bain Capital Private For: May 29
-
Form D/A Bain Capital Structured
-
Form 8-K Bain Capital Private For: May 21
-
Form 4 RAPID MICRO BIOSYSTEMS, For: May 20 Filed by: Bain Capital Life Sciences Investors, LLC
-
Form 8-K Bain Capital Specialty For: May 21
-
Form 8-K Bain Capital Private For: May 21
-
Rapid Micro Biosystems prices $9.8 million stock and warrant offering
-
Form SCHEDULE 13G/A Lincoln Bain Capital Filed by: LVIP GLOBAL GROWTH ALLOCATION MANAGED RISK FUND
-
Form SCHEDULE 13D/A Lincoln Bain Capital Filed by: LINCOLN NATIONAL CORP
-
Form 4 Lincoln Bain Capital For: May 14 Filed by: Lincoln Financial Investments Corp
-
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-HR Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-HR Bain Capital Prairie, For: Mar 31
-
Form 13F-NT Bain Capital Prairie For: Mar 31
-
Form 13F-NT Bain Capital Prairie For: Mar 31
-
Form SCHEDULE 13G/A Bain Capital GSS Investm Filed by: Empyrean Capital Partners, LP
-
Form SCHEDULE 13G/A Bain Capital GSS Investm Filed by: Fort Baker Capital Management LP
-
Form 13F-NT Bain Capital Partners For: Mar 31
-
Form 13F-HR BAIN CAPITAL INVESTORS For: Mar 31
-
Form 13F-NT Bain Capital Fund XI, For: Mar 31
-
Form 13F-NT Bain Capital Fund XII, For: Mar 31
-
Form 13F-NT Bain Capital Partners For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-HR BAIN CAPITAL VENTURE For: Mar 31
